According to several studies, RSK2 is closely associated with the development of various tumors, and its expression is significantly higher in tumor tissues such as glioblastoma, osteosarcoma, skin cancer, and squamous cell carcinoma compared to normal tissues [25,26,27,28]. This evidence concerns the gene RPS6KA3 and skin neoplasm.